STRAMA Sweden AMR Public Organism Hospital Antimicrobial MRSA n/a DDD/1000 (including funding and usage, infection; patient days; and (Swedish incidence and ICU reported 62 antibiotic susceptibility separately; infection testing of pneumococci annual bacterial infection; VRE reports isolates against infection; antibiotics publications (links to interactive database – ResNet) SWEDRES167 Sweden AMR Public n/a Hospitals Antimicrobial S. Public (Report of funding and usage, pneumoniae reports; STRAMA and and (Swedish community incidence and S. pyogenes consumption the Swedish antibiotic susceptibility H. influenzae DDD per Institute for testing of E. coli producing 1000 Infectious bacterial K. Entero- inhabitants Disease Control isolates against pneumoniae and per day [SMI]; antibiotics S. aureus MRSA, contributes data P. aeruginosa to Ears-Net C. difficile [ECDC]) S. pneumoniae and VRE
STRAMA (including 62 Sweden AMR and antibiotic Public funding (Swedish Organism Hospital and infection Antimicrobial usage, incidence and susceptibility testing of bacterial isolates against antibiotics MRSA infection; pneumococci infection; VRE infection; (links to interactive database – ResNet) n/a DDD/1000 patient days; ICU reported separately; annual reports publications SWEDRES167 (Report of STRAMA and the Swedish Institute for Infectious Disease Control [SMI]; contributes data to Ears-Net [ECDC]) Sweden AMR and antibiotic Public funding (Swedish n/a Hospitals and community Antimicrobial usage, incidence and susceptibility testing of bacterial isolates against antibiotics S. pneumoniae S. pyogenes H. influenzae E. coli K. pneumoniae S. aureus P. aeruginosa C. difficile producing Entero- MRSA, S. pneumoniae and VRE Public reports; consumption DDD per 1000 inhabitants and per day
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx